HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch) capsules 2.5 microg) , a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients].

AuthorsKaoru Nakao, Akihiro Ando, Mikito Hirakata, Naoki Ando, Koichiro Takeshita, Yohei Miyamoto, Hidenori Mochizuki
JournalNihon yakurigaku zasshi. Folia pharmacologica Japonica (Nihon Yakurigaku Zasshi) Vol. 135 Issue 5 Pg. 205-14 (May 2010) ISSN: 0015-5691 [Print] Japan
PMID20467170 (Publication Type: Journal Article, Review)
Chemical References
  • Capsules
  • Morphinans
  • Receptors, Opioid
  • Spiro Compounds
  • TRK 820
Topics
  • Administration, Oral
  • Animals
  • Capsules
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Humans
  • Morphinans (administration & dosage, metabolism, pharmacokinetics, pharmacology)
  • Pruritus (drug therapy, etiology)
  • Receptors, Opioid (agonists, metabolism)
  • Renal Dialysis (adverse effects)
  • Spiro Compounds (administration & dosage, metabolism, pharmacokinetics, pharmacology)
  • Uremia (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: